2025 second_quarter Filing
Q2Income
$80K
Filed
July 18, 2025
Lobbying Activities
Health IssuesView all
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (4)
CRISTINA ANTELO
DEBRA DIXON
MARK WILLIAMS
MICHAEL TAGGART